chr13-99501751-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000376387.5(TM9SF2):c.145G>A(p.Glu49Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000686 in 1,458,074 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000376387.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TM9SF2 | NM_004800.3 | c.145G>A | p.Glu49Lys | missense_variant | 1/17 | ENST00000376387.5 | NP_004791.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TM9SF2 | ENST00000376387.5 | c.145G>A | p.Glu49Lys | missense_variant | 1/17 | 1 | NM_004800.3 | ENSP00000365567.3 | ||
TM9SF2 | ENST00000642475.1 | c.145G>A | p.Glu49Lys | missense_variant | 3/19 | ENSP00000493515.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000407 AC: 1AN: 245852Hom.: 0 AF XY: 0.00000749 AC XY: 1AN XY: 133442
GnomAD4 exome AF: 6.86e-7 AC: 1AN: 1458074Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 725446
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 14, 2021 | The c.145G>A (p.E49K) alteration is located in exon 1 (coding exon 1) of the TM9SF2 gene. This alteration results from a G to A substitution at nucleotide position 145, causing the glutamic acid (E) at amino acid position 49 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at